Iloprost modulates the immune response in systemic sclerosis
<p>Abstract</p> <p>Background</p> <p>Iloprost has been suggested to possess anti-inflammatory and immunomodulating actions and it is widely use as a vasodilatator in systemic sclerosis (SSc). In this study we evaluate the effect of iloprost on immune response in SSc patients. To this extend we enrol...
Збережено в:
| Автори: | , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2010-12-01
|
| Серія: | BMC Immunology |
| Онлайн доступ: | http://www.biomedcentral.com/1471-2172/11/62 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|